Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Non-Current Debt: 2011-2012

Historic Non-Current Debt for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Dec 2012 value amounting to $424,000.

  • Sonoma Pharmaceuticals' Non-Current Debt fell 81.48% to $424,000 in Q4 2012 from the same period last year, while for Dec 2012 it was $424,000, marking a year-over-year decrease of 81.48%. This contributed to the annual value of $1.8 million for FY2012, which is 11.36% up from last year.
  • As of Q4 2012, Sonoma Pharmaceuticals' Non-Current Debt stood at $424,000, which was down 61.17% from $1.1 million recorded in Q3 2012.
  • Sonoma Pharmaceuticals' 5-year Non-Current Debt high stood at $2.3 million for Q4 2011, and its period low was $424,000 during Q4 2012.
  • In the last 2 years, Sonoma Pharmaceuticals' Non-Current Debt had a median value of $1.7 million in 2011 and averaged $1.6 million.
  • The largest annual percentage gain for Sonoma Pharmaceuticals' Non-Current Debt in the last 5 years was 11.36% (2012), contrasted with its biggest fall of 81.48% (2012).
  • Sonoma Pharmaceuticals' Non-Current Debt (Quarterly) stood at $2.3 million in 2011, then plummeted by 81.48% to $424,000 in 2012.
  • Its Non-Current Debt stands at $424,000 for Q4 2012, versus $1.1 million for Q3 2012 and $1.4 million for Q2 2012.